By down-regulating the expression of forkhead box transcription factor O1 (FoxO1), TLR4/NF-κB/NLRP3 pathway can be inhibited to alleviate PCOS and reduce inflammation and immune response (110). Here, TLR4 is linked to polycystic ovary syndrome.